The Journal of cell biology · 2004
Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway.
СтатьяПоддержка службы здравоохранения СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mikhailov Alexei, Shinohara Mio, Rieder Conly L
Аннотация
When early prophase PtK(1) or Indian muntjac cells are exposed to topoisomerase II (topo II) inhibitors that induce little if any DNA damage, they are delayed from entering mitosis. We show that this delay is overridden by inhibiting the p38, but not the ATM, kinase. Treating early prophase cells with hyperosmotic medium or a histone deacetylase inhibitor similarly delays entry into mitosis, and this delay can also be prevented by inhibiting p38. Together, these results reveal that agents or stresses that induce global changes in chromatin topology during G2 delay entry into mitosis, independent of the ATM-mediated DNA damage checkpoint, by activating the p38 MAPK checkpoint. The presence of this pathway obviates the necessity of postulating the existence of multiple "chromatin modification" checkpoints during G2. Lastly, cells that enter mitosis in the presence of topo II inhibitors form metaphase spindles that are delayed in entering anaphase via the spindle assembly, and not the p38, checkpoint.
Предметные рубрики MeSH
AclarubicinAnaphaseAntibiotics, AntineoplasticAntineoplastic AgentsBlotting, WesternCatalysisCell Line, TumorChromatinChromosomesDNA DamageDiketopiperazinesDoxorubicinEnzyme ActivationG2 PhaseHeLa CellsHistone Deacetylase InhibitorsHistonesHumansImmunohistochemistryLasersMicroscopy, VideoMitogen-Activated Protein KinasesMitosisOsmosisPiperazinesSpindle ApparatusThiobarbituratesTime FactorsTopoisomerase II Inhibitorsp38 Mitogen-Activated Protein Kinases